10-Q: Q3 2024 Earnings Report

SECNov 14 05:47 · Announcements

10-Q: Q2 2024 Earnings Report

SECAug 14 04:18 · Announcements

Adial Pharmaceuticals Signs Agreement With Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04

GlobeNewswireAug 13 21:00

Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

GlobeNewswireAug 7 21:00

Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044

GlobeNewswireJul 31 20:30

Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

GlobeNewswireJul 23 20:30